Elder Pharmaceuticals has signed an agreement with US-based MD Anderson Cancer Center to conduct human experiments for its newly-discovered anti-cancer drug.
Talking about the outlook for the pharmaceutical industry in India, KRN Moorthy, Deputy Managing Director, Wanbury said that the pharmaceutical industry should do well in the coming years.
Quick on the heels of a setback to divest its hospital chain to Apollo Hospitals, troubled Indian drugmaker, Wockhardt Ltd, which has debt of Rs3, 400 crore as on 31 December 2008, has succeeded in selling its German unit Esparma to Mova Pharma, the company announced yesterday.
After multinational drugmakers, it's the European Union's (EU) turn to exert pressure on India to agree to provisions that could affect the registration and availability of low-cost medicines.
Close on the heels of Nigerian authorities unearthing Chinese-made drugs with fake ‘Made in India’ labels, the Central Drugs Standard.
The drug lords are sniffing for deals in India.Global pharmaceutical giants, which fought bruising patent battles against Indian firms just a few years ago, have decided to bury the hatchet and forge closer ties for mutual benefit.
The Indian pharmaceutical and healthcare industry has witnessed steady growth over past years and is also expected to perform well in the future.
Watson Pharmaceuticals Inc. (WPI) has agreed to acquire privately held drug maker Arrow Group in a $1.75 billion cash and stock deal, which will expand Watson's global reach and give it exclusive initial U.S. rights for the generic version of the cholesterol-lowering drug Lipitor.
Nuvo Research is pocketing a $10 million up-front fee after forging a licensing deal with Covidien covering two topical anti-inflammatories. The developer says it will gain $15 million to $20 million more if the FDA approves Pennsaid, which is scheduled to get a regulatory decision by August 5. And another $100 million in sales milestones is on the table.
India biopharmaceutical companies' adherence to Intellectual Property (IP) is a big attraction for international companies to enter into co-development and production alliances.
A report identifying a broad range of potential benefits of incremental pharmaceutical innovation for India would be released later this week by the US India Business Council (USIBC).
The world is now at the start of the 2009 influenza pandemic says the WHO. The good news – a pharmaceutical company says it's ready with a vaccine.
Merger and acquisitions (M&As) in the domestic and international pharma industry are gradually changing the Indian pharmalandscape in favour of foreign players.
Pharma major, Dr Reddy’s Laboratories Ltd will hire 1,300 employees in various categories this year.
GlaxoSmithKline has forged a partnership with Dr. Reddy's Laboratories to sell more than 100 branded drugs, some of which are still in development.
Pfizer Inc (PFE.N), the world's largest drugmaker, is looking to conclude deals in emerging markets over coming months to raise its share of a market worth an estimated $80 billion, an executive said on Sunday.
Pharmaceutical sector striding forward on greenhouse gas emissions.
India is preparing its case on the repeated seizures at European ports of its consignments containing off-patent drugs meant for other developing nations before it moves the European Union and the World Trade Organisation (WTO), according to a commerce ministry official.
Pfizer, the world's biggest drugmaker, is seeking deals with generic pharmaceutical manufacturers to increase sales of medicines that have lost patent protection.
Large Indian companies are faced with a dilemma. Given the high expectations they have built up, the key question before them is how to grow from the present levels and keep investors hooked.